Home > Products > CD3 & PSCA
> Human Anti-CD3 x Anti-PSCA Bispecific Antibody (IgG-IgG)
Human Anti-CD3 x Anti-PSCA Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H275)
Anti-CD3 x Anti-PSCA Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD3 and anti-PSCA parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.
There are currently no customer reviews or questions for Human Anti-CD3 x Anti-PSCA Bispecific Antibody (IgG-IgG) (BSIG-H275). Click the button below to contact us or submit your feedback about this product.